The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020

BACKGROUND: In recent years, new drug development on lung cancer is in full swing in China. The aim of this study was to overview the changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020. METHODS: We analysed anti-lung cancer drug clinical trials registered...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Qiaofeng, Tao, Yunxia, Chen, Haizhu, Zhou, Yu, Huang, Liling, Han, Xiaohong, Shi, Yuankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315452/
https://www.ncbi.nlm.nih.gov/pubmed/34327360
http://dx.doi.org/10.1016/j.lanwpc.2021.100151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315452/
https://www.ncbi.nlm.nih.gov/pubmed/34327360
http://dx.doi.org/10.1016/j.lanwpc.2021.100151

Ejemplares similares